|
2014 Journal Article Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA)Foote, Celine, Clayton, Philip A., Johnson, David W., Jardine, Meg, Snelling, Paul and Cass, Alan (2014). Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA). American Journal of Kidney Diseases, 64 (3), 359-366. doi: 10.1053/j.ajkd.2014.02.023 |
|
2014 Journal Article Economic Evaluation of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions Compared With Standard Solutions: A Secondary Analysis of the balANZ TrialHoward K., Hayes A., Cho Y., Cass A., Clarke M. and Johnson D.W. (2014). Economic Evaluation of Neutral-pH, Low-Glucose Degradation Product Peritoneal Dialysis Solutions Compared With Standard Solutions: A Secondary Analysis of the balANZ Trial. American Journal of Kidney Diseases, 65 (5), 773-779. doi: 10.1053/j.ajkd.2014.12.017 |
|
2014 Journal Article SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trialRossi, Megan, Johnson, David W., Morrison, Mark, Pascoe, Elaine, Coombes, Jeff S., Forbes, Josephine M., McWhinney, Brett C., Ungerer, Jacobus P. J., Dimeski, Goce and Campbell, Katrina L. (2014). SYNbiotics Easing Renal failure by improving Gut microbiologY (SYNERGY): a protocol of placebo-controlled randomised cross-over trial. BMC Nephrology, 15 (1) 106, 106.1-106.10. doi: 10.1186/1471-2369-15-106 |
|
2014 Journal Article HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysisPalmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Johnson, David W., Perkovic, Vlado, Hegbrant, Jorgen and Strippoli, Giovanni F.M. (2014). HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis. Cochrane Database of Systematic Reviews, 2014 (5) CD007784. doi: 10.1002/14651858.CD007784.pub2 |
|
2014 Journal Article Treatment for peritoneal dialysis-associated peritonitisBallinger, Angela E., Palmer, Suetonia C., Wiggins, Kathryn J., Craig, Jonathan C., Johnson, David W., Cross, Nicholas B. and Strippoli, Giovanni F.M. (2014). Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database of Systematic Reviews, 2014 (4) CD005284. doi: 10.1002/14651858.CD005284.pub3 |
|
2014 Journal Article A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patientsCampbell, Katrina L., Johnson, David W., Bauer, Judith, Hawley, Carmel M., Isbel, Nicole M., Stowasser, Michael, Whitehead, Jonathan P., Dimeski, Goce and McMahon, Emma (2014). A randomized trial of sodium-restriction on kidney function, fluid volume and adipokines in CKD patients. BMC Nephrology, 15 (1) 57, 57.1-57.6. doi: 10.1186/1471-2369-15-57 |
|
2014 Journal Article The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitisTang, Wen, Cho, Yeoungjee, Hawley, Carmel M., Badve, Sunil V. and Johnson, David W. (2014). The role of monitoring gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis. Peritoneal Dialysis International, 34 (2), 219-226. doi: 10.3747/pdi.2012.00318 |
|
2014 Journal Article Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?Cho, Yeoungjee and Johnson, David W. (2014). Does the use of neutral pH, low glucose degradation product peritoneal dialysis fluids lead to better patient outcomes?. Current Opinion in Nephrology and Hypertension, 23 (2), 192-197. doi: 10.1097/01.mnh.0000441046.13912.1f |
|
2014 Journal Article Biocompatible dialysis fluids for peritoneal dialysisCho, Yeoungjee, Johnson, David W., Craig, Jonathan C., Strippoli, Giovanni F.M., Badve, Sunil V. and Wiggins, Kathryn J. (2014). Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database of Systematic Reviews, 2014 (3) CD007554. doi: 10.1002/14651858.CD007554.pub2 |
|
2014 Journal Article Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysisBose, Bhadran, Badve, Sunil V., Hiremath, Swapnil S., Boudville, Neil, Brown, Fiona G., Cass, Alan, De Zoysa, Janak R., Fassett, Robert G., Faull, Randall, Harris, David C., Hawley, Carmel M., Kanellis, John, Palmer, Suetonia C., Perkovic, Vlado, Pascoe, Elaine M., Rangan, Gopala K., Walker, Robert J., Walters, Giles and Johnson, David W. (2014). Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis. Nephrology Dialysis Transplantation, 29 (2), 406-413. doi: 10.1093/ndt/gft378 |
|
2014 Journal Article Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studiesRuospo, Marinella, Palmer, Suetonia C., Craig, Jonathan C., Gentile, Giorgio, Johnson, David W., Ford, Pauline J., Tonelli, Marcello, Petruzzi, Massimo, De Benedittis, Michele and Strippoli, Giovanni F.M. (2014). Prevalence and severity of oral disease in adults with chronic kidney disease: a systematic review of observational studies. Nephrology Dialysis Transplantation, 29 (2), 364-375. doi: 10.1093/ndt/gft401 |
|
2014 Journal Article HMG CoA reductase inhibitors (statins) for kidney transplant recipientsPalmer, Suetonia C., Navaneethan, Sankar D., Craig, Jonathan C., Perkovic, Vlado, Johnson, David W., Nigwekar, Sagar U., Hegbrant, Jorgen and Strippoli, Giovanni F.M. (2014). HMG CoA reductase inhibitors (statins) for kidney transplant recipients. Cochrane Database of Systematic Reviews, 2014 (1) CD005019, 1-64. doi: 10.1002/14651858.CD005019.pub4 |
|
2014 Journal Article Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophyMorais, Christudas, Small, David M., Vesey, David A., Martin, Jennifer, Johnson, David W. and Gobe, Glenda C. (2014). Fibronectin and transforming growth factor beta contribute to erythropoietin resistance and maladaptive cardiac hypertrophy. Biochemical and Biophysical Research Communications, In Press, Corrected Proof (3), 1-6. doi: 10.1016/j.bbrc.2014.01.047 |
|
2014 Journal Article Chronic kidney disease: Haemodialysis catheter care in practiceBadve, Sunil V. and Johnson, David W. (2014). Chronic kidney disease: Haemodialysis catheter care in practice. Nature Reviews Nephrology, 10 (3), 131-133. doi: 10.1038/nrneph.2014.3 |
|
2014 Journal Article Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patientsCho, Yeoungjee, Johnson, David W., Vesey, David A., Hawley, Carmel M., Pascoe, Elaine M., Clarke, Margaret, Topley, Nicholas and on behalf of the balANZ Trial Investigators (2014). Dialysate interleukin-6 predicts increasing peritoneal solute transport rate in incident peritoneal dialysis patients. BMC Nephrology, 15 (1) 8. doi: 10.1186/1471-2369-15-8 |
|
2014 Journal Article Association between GFR estimated by multiple methods at dialysis commencement and patient survivalWong M.G., Pollock C.A., Cooper B.A., Branley P., Collins J.F., Craig J.C., Kesselhut J., Luxton G., Pilmore A., Harris D.C. and Johnson D.W. (2014). Association between GFR estimated by multiple methods at dialysis commencement and patient survival. Clinical Journal of the American Society of Nephrology, 9 (1), 135-142. doi: 10.2215/CJN.02310213 |
|
2014 Journal Article Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell linesBennett, Nigel C., Hooper, John D., Johnson, David W. and Gobe, Glenda C. (2014). Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines. Prostate, 74 (5), 478-487. doi: 10.1002/pros.22767 |
|
2014 Journal Article Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trialJohnson, David W., Badve, Sunil V., Pascoe, Elaine M., Beller, Elaine, Cass, Alan, Clark, Carolyn, de Zoysa, Janak, Isbel, Nicole M., McTaggart, Steven, Morrish, Alicia T., Playford, E. Geoffrey, Scaria, Anish, Snelling, Paul, Vergara, Liza A., Hawley, Carmel M. and for the HONEYPOT Study Collaborative Group (2014). Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial. The Lancet Infectious Diseases, 14 (1), 23-30. doi: 10.1016/S1473-3099(13)70258-5 |
|
2014 Journal Article Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomesCho, Yeoungjee and Johnson, David W. (2014). Peritoneal dialysis-related peritonitis: Towards improving evidence, practices, and outcomes. American Journal of Kidney Diseases, 64 (2), 278-289. doi: 10.1053/j.ajkd.2014.02.025 |
|
2014 Journal Article Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials NetworkMorrish, A.T., Hawley, C.M., Johnson, D.W., Badve, S.V., Perkovic, V., Reidlinger, D.M. and Cass, A. (2014). Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network. Kidney International, 85 (1), 23-30. doi: 10.1038/ki.2013.391 |
